Direct evidence gap on fixed versus adjusted‐dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: Systematic review and individual patient data meta‐analysis-Reference-Cited by-同舟云学术

Direct evidence gap on fixed versus adjusted‐dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: Systematic review and individual patient data meta‐analysis

Published:2022-12 Issue:1 Volume:28 Page:2-16
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:Tropical Med Int Health

Author:

Ciapponi Agustín¹²,Barreira Fabiana³,Perelli Lucas¹,Bardach Ariel¹²,Gascón Joaquim⁴⁵,Molina Israel⁶⁷,Morillo Carlos⁸,Prado Nilda⁹,Riarte Adelina⁹,Torrico Faustino¹⁰,Villar Juan Carlos¹¹,Reidel Sara¹,Gibbons Luz¹,Sosa‐Estani Sergio²³

Affiliation:

1. Departamento de Evaluación de Tecnologías Sanitarias Instituto de Efectividad Clínica y Sanitaria Buenos Aires Argentina

2. Centro de Investigaciones Epidemiológicas y Salud Pública Consejo Nacional de Investigaciones Científicas y Técnicas Buenos Aires Argentina

3. Chagas Clinical Project Drugs for Neglected Diseases Initiative Río de Janeiro Brazil

4. ISGlobal Hospital Clínic – Universitat de Barcelona Barcelona Spain

5. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública Madrid Spain

6. Infectious Diseases Department Hospital Universitario Vall d'Hebron Barcelona Spain

7. International Health Program Catalan Institute of Health Barcelona Spain

8. Libin Cardiovascular Institute University of Calgary Calgary Canada

9. Instituto Nacional de Parasitología Dr. M Fatala Chaben Ministerio de Salud de la Nación Buenos Aires Argentina

10. Parasitología y Enfermedades Infecciosas Universidad Mayor de San Simón Cochabamba Bolivia

11. Departamento de Investigaciones Fundación Cardioinfantil, Instituto de Cardiología Bogotá Colombia

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tmi.13831

Reference67 articles.

1. IHME.Chagas disease—level 3 cause.2021. Available from:https://www.healthdata.org/results/gbd_summaries/2019/chagas-disease-level-3-cause

2. Global economic burden of Chagas disease: a computational simulation model

3. WHO.Chagas disease (American trypanosomiasis).2021. Available from:https://www.who.int/health-topics/chagas-disease#tab=tab_1

4. An Estimate of the Burden of Chagas Disease in the United States

5. WHO.Control and prevention of Chagas disease in Europe.2010. Available from:https://apps.who.int/iris/rest/bitstreams/447320/retrieve. Accessed 2 Nov 2018.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of parasitemia by qPCR in patients with chronic Chagas disease treated with benznidazole;Asian Pacific Journal of Tropical Medicine;2023-12

2. Clinical use of molecular methods for Trypanosoma cruzi infection in endemic and non-endemic countries: Benefits, limitations and challenges;Frontiers in Parasitology;2023-11-21

3. Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease;PLOS ONE;2023-09-08

4. Pharmacological potential of new metronidazole/eugenol/dihydroeugenol hybrids against Trypanosoma cruzi in vitro and in vivo;International Immunopharmacology;2023-08